CA2183952A1 - Produit ou comprime granulaire contenant un systeme effervescent et un principe actif pharmaceutique, et son procede de preparation - Google Patents

Produit ou comprime granulaire contenant un systeme effervescent et un principe actif pharmaceutique, et son procede de preparation

Info

Publication number
CA2183952A1
CA2183952A1 CA002183952A CA2183952A CA2183952A1 CA 2183952 A1 CA2183952 A1 CA 2183952A1 CA 002183952 A CA002183952 A CA 002183952A CA 2183952 A CA2183952 A CA 2183952A CA 2183952 A1 CA2183952 A1 CA 2183952A1
Authority
CA
Canada
Prior art keywords
acid
granular product
effervescent system
preparation
well
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002183952A
Other languages
English (en)
Other versions
CA2183952C (fr
Inventor
Thomas Gergely
Stefan Gergely
Gerhard Gergely
Irmgard Gergely
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP94203112A external-priority patent/EP0670160B1/fr
Application filed by Individual filed Critical Individual
Publication of CA2183952A1 publication Critical patent/CA2183952A1/fr
Application granted granted Critical
Publication of CA2183952C publication Critical patent/CA2183952C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002183952A 1994-03-01 1995-02-23 Produit ou comprime granulaire contenant un systeme effervescent et un principe actif pharmaceutique, et son procede de preparation Expired - Fee Related CA2183952C (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
DE4406641 1994-03-01
DEP4406641.4 1994-03-01
CH873/94-6 1994-03-23
CH87394 1994-03-23
EP94203112A EP0670160B1 (fr) 1994-03-01 1994-10-26 Produit granulaire ou comprimé contenant un système effervescent et un agent actif pharmaceutique, et son procédé de préparation
EP94203112.1 1994-10-26
PCT/EP1995/000650 WO1995023594A1 (fr) 1994-03-01 1995-02-23 Produit ou comprime granulaire contenant un systeme effervescent et un principe actif pharmaceutique, et son procede de preparation

Publications (2)

Publication Number Publication Date
CA2183952A1 true CA2183952A1 (fr) 1995-09-08
CA2183952C CA2183952C (fr) 2007-01-16

Family

ID=27172490

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002183952A Expired - Fee Related CA2183952C (fr) 1994-03-01 1995-02-23 Produit ou comprime granulaire contenant un systeme effervescent et un principe actif pharmaceutique, et son procede de preparation

Country Status (15)

Country Link
JP (1) JPH09509669A (fr)
CN (1) CN1213739C (fr)
AU (1) AU681256B2 (fr)
BR (1) BR9506964A (fr)
CA (1) CA2183952C (fr)
CZ (1) CZ291710B6 (fr)
DE (1) DE670160T1 (fr)
FI (1) FI118033B (fr)
HU (1) HU228147B1 (fr)
NO (1) NO315308B1 (fr)
NZ (1) NZ281228A (fr)
PL (1) PL181714B1 (fr)
RU (1) RU2153331C2 (fr)
TW (1) TW403658B (fr)
WO (1) WO1995023594A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9388053B2 (en) 2011-12-09 2016-07-12 Merck Patent Gmbh Anhydrous sodium carbonate having a low pore content

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US20030070584A1 (en) 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
US8309118B2 (en) 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
DE10224607B4 (de) * 2002-06-04 2008-03-13 Lts Lohmann Therapie-Systeme Ag Filmförmige, zerfallsfähige Zubereitungen zur Wirkstofffreisetzung und Verfahren zu deren Herstellung
WO2004050068A1 (fr) * 2002-11-29 2004-06-17 Janssen Pharmaceutica N.V. Compositions pharmaceutiques comprenant un compose medicamenteux respectivement basique, tensioactif et base respectivement acide hydrosoluble et tolerable physiologiquement
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
JPWO2006059716A1 (ja) * 2004-12-03 2008-06-05 武田薬品工業株式会社 固形製剤
WO2011105539A1 (fr) * 2010-02-26 2011-09-01 東レ株式会社 Préparation solide enrobée
US20150289554A1 (en) * 2012-10-25 2015-10-15 Otc Nutrition Llc Fast Dissolving Solid Calcium Mineral Supplement Compositions and Processing Making
KR102253847B1 (ko) 2012-12-19 2021-05-21 바이엘 애니멀 헬스 게엠베하 향상된 수용성 및 우수한 저장 안정성을 가지는 정제
CN105670003A (zh) * 2014-11-21 2016-06-15 常州坤宇环保科技有限公司 高吸水树脂防结块剂
EP3318135A1 (fr) * 2016-11-03 2018-05-09 Perfetti Van Melle S.p.A. Matériau de bonbon effervescent, son procédé de préparation et produits fabriqués à partir de celui-ci
BR112022007397A2 (pt) * 2019-10-17 2022-09-20 Isp Investments Llc Composição excipiente coprocessada efervescente estável e processo para sua preparação

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1039170A (en) * 1969-02-24 1971-07-22 Abbott Laboratories Tableting medium
US4704269A (en) * 1985-06-11 1987-11-03 Hudson Pharmaceutical Corporation Effervescent antacid and analgesic compositions
CA2023493C (fr) * 1989-08-31 2000-01-04 Masami Moroi Melange servant a l'administration d'un produit moussant
EP0592484B1 (fr) * 1991-07-01 1995-01-18 Gergely, Gerhard, Dr. Systemes effervescents dopes avec des reactifs

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9388053B2 (en) 2011-12-09 2016-07-12 Merck Patent Gmbh Anhydrous sodium carbonate having a low pore content

Also Published As

Publication number Publication date
DE670160T1 (de) 1996-03-14
CN1213739C (zh) 2005-08-10
PL316113A1 (en) 1996-12-23
FI118033B (fi) 2007-06-15
CZ251996A3 (en) 1997-01-15
AU1811495A (en) 1995-09-18
WO1995023594A1 (fr) 1995-09-08
AU681256B2 (en) 1997-08-21
HUT75677A (en) 1997-05-28
RU2153331C2 (ru) 2000-07-27
NO963588D0 (no) 1996-08-28
TW403658B (en) 2000-09-01
CA2183952C (fr) 2007-01-16
CZ291710B6 (cs) 2003-05-14
FI963385A (fi) 1996-10-30
HU228147B1 (en) 2012-12-28
NZ281228A (en) 1997-06-24
JPH09509669A (ja) 1997-09-30
NO315308B1 (no) 2003-08-18
NO963588L (no) 1996-10-31
FI963385A0 (fi) 1996-08-30
BR9506964A (pt) 1997-09-09
PL181714B1 (en) 2001-09-28
HU9602380D0 (en) 1996-10-28
CN1142182A (zh) 1997-02-05

Similar Documents

Publication Publication Date Title
DK0670160T3 (da) Granulært præparat eller tablet omfattende et brusemiddel og et aktivt farmaceutisk stof samt fremgangsmåde til dets fremst
CA2183952A1 (fr) Produit ou comprime granulaire contenant un systeme effervescent et un principe actif pharmaceutique, et son procede de preparation
CA1328403C (fr) Systeme therapeutique pour des ingredients actifs moderement solubles
CA2213996A1 (fr) Formes galeniques par voie orale comprenant un inhibiteur de la pompe a protons et un agent antiacide ou un alginate
CA2101779A1 (fr) Composition de demoussage
CA2286753A1 (fr) Preparation pharmaceutique solide
CA2234957A1 (fr) Administration de medicaments insolubles
CA2136848A1 (fr) Plaquettes de sang humain fixees et sechees, a caracteristiques pharmaceutiques acceptables
CA2039456A1 (fr) Appareil de dosage osmotique pour l'administration de medicaments liquides
SE502590C2 (sv) Oralt terapeutiskt system innehållande karbamazepin med systemisk verkan, förfarande för framställning och användning därav
IE862785L (en) Effervescent ibuprofen composition
CA2344678A1 (fr) Systeme d'administration locale demi-sec
CA2059865A1 (fr) Compositions pharmaceutiques contenant des glycosaminoglycans absorbables par voie orale
EP1334728A3 (fr) Agents Antithrombotiques
AU679200B2 (en) Effervescent pharmaceutical composition containing ibuprofenand method for preparing same
CA2290504A1 (fr) Pastilles et leur procede de production
CA2396223A1 (fr) Granules instantanes et procede pour leur formulation
RU96120083A (ru) Гранулированный продукт или таблетка, содержащие шипучую систему и активное фармацевтическое средство, а также способ их получения
CA2000932A1 (fr) Forme pharmaceutique orale multiparticulaire a liberation controlee
FI71058B (fi) Foerfarande foer framstaellning av en magsyraneutraliserande suspension
PL168421B1 (en) Method of obtaining a pharmaceutic composition for treating stomach disorders
CA2184581A1 (fr) Amelioration des solutions liquides d'adn-ase
EP0715520B1 (fr) Utilisatioin d'une suspension a base de gel de sucralphate comme antiacide
CA2218370A1 (fr) Comprime a macher a action effervescente
CA2213775A1 (fr) Inhibiteur de metastases cancereuses contenant un polysaccharide de surface de streptococcus agalactiae de type ia ou de type ib comme composant principal

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed